| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Lu Y.S;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Chih-Hsin Yang;Cheng A.L.; Yeh K.H; Lu Y.S; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; CHIH-HSIN YANG; Cheng A.L. |
| 臺大學術典藏 |
2021-09-01T02:02:18Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; ANN-LII CHENG |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2003-04 |
Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy
|
Chen, Y;Lee, C;Lin, W;Tsai, C;Perng, R |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.;Chiun-Sheng Huang;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Hsu C.; CHIUN-SHENG HUANG; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.;Chang K.-J;Chen M.M;Bu C.-F;Yen-Shen Lu;Chao T.-Y;Huang C.-S;Hsu C; Hsu C; Huang C.-S; Chao T.-Y; YEN-SHEN LU; Bu C.-F; Chen M.M; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-08-12T06:28:23Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; KING-JEN CHANG; Cheng A.-L. |
| 國立臺灣大學 |
2002 |
Phase Ii Trial Combining Paclitaxel with 24-Hour Infusion Cisplatin for Chemotherapy-Naive Patients with Locally Advanced or Metastatic Breast Carcinoma
|
許駿; 黃俊升; 張金堅; 鄭安理; HSU, CHIUN; HUANG, CHIUN-SHENG; CHANG, KING-JEN; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T04:17:34Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
|
Hsu, C.;Huang, C.-S.;Chao, T.-Y.;Lu, Y.-S.;Bu, C.-F.;Chen, M.M.;Chang, K.-J.;Cheng, A.-L.; CHIUN-SHENG HUANG; ANN-LII CHENG |
| 臺大學術典藏 |
2020-04-10T12:51:30Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
|
Chiun Hsu;Huang C.-S.;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Chiun Hsu; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
|
Chua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T. |
| 國立臺灣大學 |
2009 |
Phase Ii Trial of Carboplatin and Distearoylphosphatidylcholine Pegylated Liposomal Doxorubicin (Lipo-Dox) in Recurrent Platinum-Sensitive Ovarian Cancer Following Front-Line Therapy with Paclitaxel and Platinum
|
蕭聖謀; 陳祈安; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG |
| 臺大學術典藏 |
2020-01-22T07:50:43Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.; CHI-AN CHEN; Lin H.-H.; Hsieh C.-Y.; Wei L.-H. |
| 臺大學術典藏 |
2020-02-12T05:48:29Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M; Chen C.-A; Lin H.-H; Hsieh C.-Y; LING-HUNG WEI |
| 臺大學術典藏 |
2020-02-17T08:51:02Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M; Chen C.-A; HO-HSIUNG LIN; Hsieh C.-Y; Wei L.-H. |
| 臺大學術典藏 |
2020-11-27T08:14:22Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.; Chen C.-A.; Lin H.-H.; CHANG-YAO HSIEH; Wei L.-H. |
| 臺大學術典藏 |
2021-03-03T03:01:14Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.;Chen C.-A.;Ho-Hsiung Lin;Hsieh C.-Y.;Wei L.-H.; Hsiao S.-M.; Chen C.-A.; HO-HSIUNG LIN; Hsieh C.-Y.; Wei L.-H. |
| 臺大學術典藏 |
2018-09-10T07:47:35Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox®) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao, S.-M. and Chen, C.-A. and Lin, H.-H. and Hsieh, C.-Y. and Wei, L.-H.; CHI-AN CHEN; HO-HSIUNG LIN |
| 中國醫藥大學 |
2005 |
Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx
|
Wang, HM; Hsueh, CT; Wang, CS; Chen, IH; Liao, CT; Tsai, MH; Yeh, SP; Chang, JTC |
| 國立臺灣大學 |
1994 |
Phase II Trial of Intra-Peritoneal Hyperthermo-Chemotherapy in Patients with resected Gastric Cancer
|
Lee, W. J.; Wei, T. C.; Yu, S. C.; 游憲章; Chang, K. J.; 陳楷模; Lee, W. J.; Wei, T. C.; Yu, S. C.; Yu, Sen-Chang; Chang, K. J.; Chen, Kai-Mo |
| 國立臺灣大學 |
1985 |
Phase II Trial of Intraperitoneal Hyperthermo-Chemotherapy in Patients with Resected Gastric Cancer
|
魏達成; Lee, W. J.; Yu, S. C.; 游憲章; Chang, K. J.; 陳楷模; Wei, Ta-Cheng; Lee, W. J.; Yu, S. C.; Yu, Sen-Chang; Chang, K. J.; Cheng, K. M. |
